The burden of influenza A and B in Mexico from the year 2010 to 2013: An observational, retrospective, database study, on records from the Directorate General of Epidemiology database

References

• Echevarría-Zuno S, Grajales-Muñiz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374:2072–9. doi:10.1016/S0140-6736(09)61638-X. PMID:19913290
   PubMed Web of Science ®Google Scholar
• Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302:1880–7. doi:10.1001/jama.2009.1536. PMID:19822626
   PubMed Web of Science ®Google Scholar
• Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, Borja-Aburto VH. Characterizing the Epidemiology of the 2009 Influenza A/H1N1 Pandemic in Mexico. doi:10.1371/journal.pmed.1000436
   Google Scholar
• Rothberg MB, Haessler SD, Brown RB. Complications of Viral Influenza. American Journal of Medicine. 2008;121:258–64. doi:10.1016/j.amjmed.2007.10.040. PMID:18374680
   PubMed Web of Science ®Google Scholar
• Secretaría de Salud. Vacunación universal y semanas nacionales de salud lineamientos generales. Centro Nacional para la Salud de Niños, Niñas y Adolescentes de México. 2008
   Google Scholar
• Secretaría de Salud. NORMA Oficial Mexicana NOM-036-SSA2-2002, Prevención y control de enfermedades. Aplicación de vacunas, toxoides, sueros, antitoxinas e inmunoglobulinas en el humano. Available at http://www.salud.gob.mx/unidades/cdi/nom/036ssa202.html. 2002
   Google Scholar
• Dávila J, Chowell G, Borja-Aburto VH, Viboud C, Grajales Muñiz C, Miller M. Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity. PLoS Curr. 2014;6:
   PubMedGoogle Scholar
• Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Grajales Muñiz C, Rascón Pacheco RA, González León M, Borja Aburto VH. Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity. PLoS Curr. 2012;4:RRN1306. doi:10.1371/currents.RRN1306. PMID:22485199
   PubMedGoogle Scholar
• Borja-Aburto VH, Chowell G, Viboud C, Simonsen L, Miller MA, Grajales-Muñiz C, González-Bonilla CR, Diaz-Quiñonez JA, Echevarría-Zuno S. Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch. Med. Res. 2012;43:563–70. doi:10.1016/j.arcmed.2012.09.005. PMID:23079035
   PubMed Web of Science ®Google Scholar
• Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Miller MA, Fernández-Gárate I, González-Bonilla C, Borja-Aburto VH. Epidemiological Characteristics and Underlying Risk Factors for Mortality during the Autumn 2009 Pandemic Wave in Mexico. PLoS One. 2012;7:e41069. doi:10.1371/journal.pone.0041069. PMID:22815917
   PubMed Web of Science ®Google Scholar
• Chowell G, Viboud C, Simonsen L, Miller MA, Echevarría-Zuno S, González-León M, Aburto VH. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico. BMC Infect. Dis. 2012;12:97. doi:10.1186/1471-2334-12-97. PMID:22520743
   PubMed Web of Science ®Google Scholar
• Secretaria de Salud. Manual de Procedimientos Estadarizados para la Vigilancia Epidemiologica de la Influenza. Secretaria de Salud. Subsecretaria de Prevencion y promocion de la Salud Direccionj General de Epidemiologia, 2012
   Google Scholar
• FluNet. WHO | FluNet - CHARTS. WHO Available at: http://www.who.int/influenza/gisrs_laboratory/flunet/charts/en/. (Accessed: 18th December 2017)
   Google Scholar
• Secretaría de Salud. NOM-036-SSA2-2012, Prevención y control de enfermedades. Aplicación de vacunas, toxoides, faboterápicos e inmunoglobulinas en el humano. 2012. Available at: https://www.gob.mx/salud/documentos/nom-036-ssa2-2012-prevencion-y-control-de-enfermedades-aplicacion-de-vacunas-toxoides-faboterapicos-e-inmunoglobulinas-en-el-humano. (Accessed: 28th February 2018)
   Google Scholar
• Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018. MMWR. Morb. Mortal. Wkly. Rep. 2018;67:180–5. doi:10.15585/mmwr.mm6706a2. PMID:29447141
   PubMed Web of Science ®Google Scholar
• World Heath Organisation. Global Influenza Surveillance and Response System GISRS. Number of specimens positive for influenza by subtype, Mexico, 2012-2013. Searchable Database 2012. Available at: http://apps.who.int/flumart/Default?ReportNo=7. (Accessed: 18th December 2017)
   Google Scholar
• 2011-2012 Flu Season Draws to a Close | Spotlights (Flu) | CDC. Centers for DIsease Control and Prevention 2012. Available at: https://www.cdc.gov/flu/spotlights/2011-2012-flu-season-wrapup.htm. (Accessed: 18th December 2017)
   Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, et al. A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season. Clin. Infect. Dis. 2012;55:332–42. doi:10.1093/cid/cis431. PMID:22539661
   PubMed Web of Science ®Google Scholar
• Fowlkes A, Steffens A, Temte J, Lonardo SD, McHugh L, Martin K, Rubino H, Feist M, Davis C, Selzer C, et al. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009–13. Lancet Respir. Med. 2015;3:709–18. doi:10.1016/S2213-2600(15)00278-7. PMID:26300111
   PubMed Web of Science ®Google Scholar
• Chen R, Holmes EC. The Evolutionary Dynamics of Human Influenza B Virus. J. Mol. Evol. 2008;66:655–63. doi:10.1007/s00239-008-9119-z. PMID:18504518
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum. Vaccin. Immunother. 2012;8:81–88. doi:10.4161/hv.8.1.17623. PMID:22252006
   PubMed Web of Science ®Google Scholar
• Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respi. Viruses. 2015;9:3–12. doi:10.1111/irv.12319
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). Recommended composition of influenza virus vaccines for use in the 2017– 2018 northern hemisphere influenza season. 2017
   Google Scholar
• Pan Y, Zhang Y, Yang P, Qian H, Shi W, Wu S, Cui S, Zhang D, Wang Q. Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015. Medicine (Baltimore). 2015;94:e2399. doi:10.1097/MD.0000000000002399. PMID:26717393
   PubMed Web of Science ®Google Scholar
• Moa AM, Muscatello DJ, Turner RM, MacIntyre CR. Epidemiology of influenza B in Australia: 2001-2014 influenza seasons. Influenza Other Respi. Viruses. 2017;11:102–9. doi:10.1111/irv.12432
   PubMed Web of Science ®Google Scholar
• Paiva TM, Benega MA, Silva DB, Santos KC, Cruz AS, Hortenci MF, Barbieri MT, Monteiro MM, Barbosa HA, Carvalhanas TR. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy. J. Med. Virol. 2013;85:1983–9. doi:10.1002/jmv.23684. PMID:23926069
   PubMed Web of Science ®Google Scholar
• Sočan M, Prosenc K, Učakar V. Berginc NA comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection. J. Clin. Virol. 2014;61:156–60. doi:10.1016/j.jcv.2014.06.018. PMID:25034374
   PubMed Web of Science ®Google Scholar
• Lagacé-Wiens PRS, Rubinstein E, Gumel A. Influenza epidemiology—past, present, and future. Crit. Care Med. 2010;38:e1–e9. doi:10.1097/CCM.0b013e3181cbaf34. PMID:20029350
   PubMed Web of Science ®Google Scholar
• Bodewes R., de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin. Vaccine Immunol. 2011;18:469–76. doi:10.1128/CVI.00396-10. PMID:21209157
   PubMed Web of Science ®Google Scholar
• Barr IG, Vijaykrishna D, Sullivan SG. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season. Eurosurveillance. 2016;21:30118. doi:10.2807/1560-7917.ES.2016.21.4.30118
   Web of Science ®Google Scholar
• Tan Y, Guan W, Lam TT, Pan S, Wu S, Zhan Y, Viboud C, Holmes EC, Yang Z. Differing Epidemiological Dynamics of Influenza B Virus Lineages in Guangzhou, Southern China, 2009-2010. J. Virol. 2013;87:12447–56. doi:10.1128/JVI.01039-13. PMID:24027322
   PubMed Web of Science ®Google Scholar
• Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, et al. The contrasting phylodynamics of human influenza B viruses. Elife. 2015;4:e05055. doi:10.7554/eLife.05055. PMID:25594904
   PubMed Web of Science ®Google Scholar
• Sharabi S, Drori Y, Micheli M, Friedman N, Orzitzer S, Bassal R, Glatman-Freedman A, Shohat T, Mendelson E, Hindiyeh M, et al. Epidemiological and Virological Characterization of Influenza B Virus Infections. PLoS One. 2016;11:e0161195. doi:10.1371/journal.pone.0161195. PMID:27533045
   PubMed Web of Science ®Google Scholar
• Cox N. Influenza seasonality: timing and formulation of vaccines. Bull. World Health Organ. 2014;92:311–311. doi:10.2471/BLT.14.139428. PMID:24839317
   PubMed Web of Science ®Google Scholar
• Wenger JB, Naumova EN. Seasonal Synchronization of Influenza in the United States Older Adult Population. PLoS One. 2010;5:e10187. doi:10.1371/journal.pone.0010187. PMID:20419169
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013–2014 Influenza Season. J. Infect. Dis. 2015;212:726–39. doi:10.1093/infdis/jiv177. PMID:25784728
   PubMed Web of Science ®Google Scholar
• Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, et al. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Eurosurveillance. 2016;21:30168. doi:10.2807/1560-7917.ES.2016.21.11.30168. PMID:27020673
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, et al. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveill. 2017;22(6):30460. doi:10.2807/1560-7917.ES.2017.22.6.30460. PMID:28205503
   PubMedGoogle Scholar
• Ascencio RL, Block MÁG. Assessment of the National Health Information System of Mexico. 2006
   Google Scholar
• Mosqueda-Gómez JL, Belaunzarán-Zamudio PF, Barba A, Córdova-Villalobos JA, Cuellar-Rodríguez JM, Ernesto Macías A. Surveillance of Oseltamivir-Resistant Influenza A(H1N1)pdm09 in Guanajuato State, Mexico from 2009 to 2012
   Google Scholar